Inogen | INGN - Market Capitalization


Inogen reported $162.6M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
AngioDynamics USD 511M 94M Sep/2025
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.43B 12M May/2026
Baxter International USD 8.67B 1.15B Mar/2026
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Boston Scientific USD 93.26B 48.09B Mar/2026
Chart Industries USD 8.78B 1.08B May/2026
Cooper Companies USD 15.95B 2.05B Dec/2025
Dexcom USD 24.17B 1.72B Mar/2026
Edwards Lifesciences USD 46.17B 3.3B Mar/2026
Globus Medical USD 11.69B 3.95B Dec/2025
Insulet USD 20B 1.74B Dec/2025
Masimo USD 6.84B 839M Dec/2025
Orthofix International USD 604M 25M Dec/2025
Philips EUR 22.38B 192.58M Dec/2025
ResMed USD 32.7B 2.46B Mar/2026
Steris USD 24.88B 511M Dec/2025
Stryker USD 125.85B 8.57B Mar/2026
Tandem Diabetes Care USD 1.49B 670M Dec/2025
Teleflex USD 5.39B 91M Dec/2025
X T L Biopharmaceuticals USD 22M 8M Dec/2024
Zimmer Biomet Holdings USD 17.5B 321M Mar/2026